Biploar Animations – Treatment Animations

New Data, New Directions In Management Of Mood And Anxiety Disorders - 8th International Forum For Mood And Anxiety Disorders Congress
Clinicians and researchers from around the world attended this week's 8th International Forum on Mood and Anxiety disorders in Vienna, Austria to discuss the latest advances in the treatment of mood disorders. A wide range of topics were included in this year's programme, highlighting the position of IFMAD in the congress calendar as a forum for breaking news, original thinking and debate.

Schizophrenia And Bipolar Disorder - Clinical Feasibility Of Once-a-Day Ziprasidone
Lipocine Inc., a specialty pharmaceutical company that uses clinically validated proprietary technologies to address key unmet drug delivery and therapeutic needs, today announced the successful completion of a clinical study that establishes feasibility of the first once-a-day dosing product for Ziprasidone, a leading treatment for schizophrenia and bipolar disorder. - Schizophrenia affects 1% of the population and bipolar disorder affects 5.7M adults in the US*.

SEROQUEL XR™ And SEROQUEL(R) Approved In Europe For New Indications For The Treatment Of Bipolar Disorder
AstraZeneca today announced that the once-daily formulation SEROQUEL XR™ (quetiapine fumarate extended release tablets) and SEROQUEL® (quetiapine fumarate) have been approved via the Mutual Recognition Procedure for new indications in bipolar disorder. SEROQUEL XR and SEROQUEL have been approved for treatment of major depressive episodes in bipolar disorder. Additionally, SEROQUEL XR has been approved for treatment of moderate to severe manic episodes in bipolar disorder.

Repligen Initiates Phase 2b Clinical Trial Of RG2417 In Bipolar Disorder
Repligen Corporation (Nasdaq: RGEN) announced that the Company has initiated a Phase 2b clinical trial to evaluate the use of RG2417, an oral formulation of uridine, in patients with bipolar depression. This Phase 2b study is a multi-center, randomized, double-blind, placebo-controlled clinical trial in which approximately 150 patients with bipolar depression will receive either RG2417 or placebo twice daily for eight weeks.

One In Five Hospital Admissions Are For Patients With Mental Disorders, USA
About 1.4 million hospitalizations in 2006 involved patients who were admitted for a mental illness, while another 7.1 million patients had a mental disorder in addition to the physical condition for which they were admitted, according to the latest News and Numbers from the Agency for Healthcare Research and Quality. The 8.5 million hospitalizations involving patients with mental illness represented about 22 percent of the overall 39.5 million hospitalizations in 2006.

Bipolar Disorder Involves A Lower Quality Of Both Mental And Physical Life, Even In Periods Of Normality
A study carried out in the Institute of Neurosciences of the University of Granada (Spain) and the Mental Health Unit of the Hospital Neurotraumatológico of Jaen (Spain) has evaluated the quality of life of patients suffering from bipolar disorder (BD), in comparison with the general population, and which variables are connected with patients with a lower quality of life.

During A Response-Imaging Task, MRI Brain Activity In First-Episode Bipolar Mania
Impulsiveness can be a common feature of mania, particularly the inability to inhibit behavioral responses. This neuroimaging study examined bipolar patients during their first episode of mania to clarify the brain functioning associated with response inhibition in this early phase of illness. 16 first-episode bipolar patients and 16 healthy subjects were underwent functional MRI scanning (fMRI) while performing a response inhibition task.

Both Mental And Physical Quality Of Life Affected By Bipolar Disorder
This press release is available in French and Spanish.

Two Per Cent Of People In England In Contact With NHS Specialist Mental Health Services, New Report Shows
One in 50 people in England were in contact with NHS specialist services for those with severe or enduring mental health problems in 2006-07, according to a new report by The NHS Information Centre. The number accessing specialist services, which cover care by specialist psychiatric teams in hospital or in the community, has risen over the four years covered by the report, reaching more than 1.1 million in 2006-07.

Patient Groups Tackle Stigma Attached To Bipolar Disorder And Other Mental Illnesses With New Tools
Mental illness is one of the last surviving stigmas in today's liberal society. Class, race, religion, gender and sexual orientation, are all off-limits now as reasons for discrimination, social exclusion, jokes or disparaging remarks of any kind. Where these are concerned, we've come a long way in terms of tolerance, fairness and sensitivity to the feelings of others; as a rule, words are chosen carefully so as not to offend and legislation ensures fair treatment.

Healthcare Commission Needs To Raise The Bar For Mental Health Service Users, UK
Commenting on the Annual Health check, Lisa Rodrigues, Chair of the

Manhattan Research Announces Top Condition Groups Shifting Their TV Viewing Online
Acne and attention deficit hyperactivity disorder (ADHD) patients are the condition groups most likely to watch streaming or downloaded television programs on the Internet, according to pharmaceutical and healthcare market research company Manhattan Research's just released Cybercitizen® Health v8.0 consumer study and strategic advisory service. The study also found that consumer media preferences overall are evolving - less than half of U.S.

Awareness Campaign - To Dispel Myths About Mood Disorders - Mood Disorders Association Of Ontario
The Mood Disorders Association of Ontario (MDAO) today launches "It's All In Your Head!" an initiative to promote awareness of the work of the MDAO and dispel myths about mental illness. Volunteers will be in the Yonge-Eglinton subway station and the Yonge-Eglinton Centre to hand out "heady" information to commuters during the evening rush hour. Mood disorders, such as depression and bipolar disorder will affect one in five individuals at some point in their life.

Childhood Bipolar Disorder Could Extend Into Young Adulthood
Young adults who had bipolar disorder as children are likely to suffer from manic episodes, according to an article released on October 6, 2008 in Archives of General Psychiatry, one of the JAMA/Archives journals. Bipolar disorder is a severe mood disorder that involves episodes of mania and depression. There is significant debate about how pediatric bipolar disorder, which affects children, should be diagnosed.

Forest Laboratories, Inc. And Gedeon Richter Plc Announce Positive Phase II Results With The Investigational Antipsychotic Cariprazine
Forest Laboratories, Inc. (NYSE: FRX) and Gedeon Richter Plc announced preliminary top-line results from a phase II clinical trial of cariprazine (RGH-188), an investigational antipsychotic, in patients with acute mania associated with bipolar I disorder.